Find More Contacts for Eli Lilly
Protected Content
Executive Finance
2 phone numbers found
View contacts for Eli Lilly to access new leads and connect with decision-makers.
View All Contacts

Details

Edit Details Section
  • Stock Symbol  EPA:LLY
  • Company Type For Profit
  • Number of Exits 
    22
  • Phone Number 1(317)276-2000

Eli Lilly engages in the discovery, development, manufacture, and sale of products in the pharmaceutical products business segment. The company manufactures and distributes products through owned or leased facilities in the United States, Puerto Rico, and 25 other countries. Its products are sold in approximately 135 countries. It also conducts

research to find products to treat diseases in animals and to increase the efficiency of animal food production.

Lists Featuring This Company

Edit Lists Featuring This Company Section
Midwestern US Public Companies With More Than 10 Employees
740 Number of Organizations • $209.2B Total Funding Amount • 720 Number of Investors
Great Lakes Public Companies With More Than 10 Employees
1,425 Number of Organizations • $371.1B Total Funding Amount • 1,847 Number of Investors
Indiana Companies With More Than $50M in Revenue
780 Number of Organizations • $23.6B Total Funding Amount • 198 Number of Investors
Medical Companies With More Than $50M in Revenue
4,412 Number of Organizations • $352B Total Funding Amount • 3,941 Number of Investors

Sub-Organizations

Edit Sub-Organizations Section
Number of Sub-Orgs 6
Which industries do these Sub-Organization operate in?

Frequently Asked Questions

Edit Frequently Asked Questions Section
Where is Eli Lilly's headquarters? Eli Lilly is located in Indianapolis, Indiana, United States.How much funding has Eli Lilly raised to date? Eli Lilly has raised
$6.5M
.When was the last funding round for Eli Lilly? Eli Lilly closed its last funding round on Feb 12, 2024 from a Post-IPO Debt round.Who are Eli Lilly's competitors? Alternatives and possible competitors to Eli Lilly may include Bristol-Myers Squibb, Pfizer, and Merck.